Fujian Cancer Hospital Reports Findings in Liver Cancer (Integrating anoikis and ErbB signaling insights with machine learning and singlecell analysis for pred icting prognosis and immune-targeted therapy outcomes in hepatocellular carcinom a)
Fujian Cancer Hospital Reports Findings in Liver Cancer (Integrating anoikis and ErbB signaling insights with machine learning and singlecell analysis for pred icting prognosis and immune-targeted therapy outcomes in hepatocellular carcinom a)
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News - New research on Oncology - Liver Cance r is the subject of a report. According to newsreporting originating from Fuzho u, People’s Republic of China, by NewsRx correspondents, research stated,“Hepat ocellular carcinoma (HCC) poses a significant global health challenge due to its poor prognosis andlimited therapeutic modalities. Anoikis and ErbB signaling p athways are pivotal in cancer cell proliferationand metastasis, but their relev ance in HCC remains insufficiently explored.”
Key words
Fuzhou/People’s Republic of China/Asia/Cancer/Carcinomas/Cyborgs/Emerging Technologies/Health and Medicine/Liver Cancer/Machine Learning/Oncology/Therapy
NETL
NSTL